CENTRIENT PHARMACEUTICALS INDI

Company Introduction: Centrient Pharmaceuticals India Private Limited

It is a factory.

Centrient Pharmaceuticals India Private Limited is the Indian subsidiary of Centrient Pharmaceuticals, a global leader in the production of sustainable antibiotics, next-generation statins, and antifungals. The company is primarily engaged in the manufacture of basic pharmaceutical products, including Active Pharmaceutical Ingredients (APIs) and intermediates. It focuses on developing and producing high-quality, sustainably manufactured pharmaceutical ingredients for the global market, contributing to the parent company's mission of providing essential medicines worldwide.

CENTRIENT PHARMACEUTICALS INDI, referring to the operations of Centrient Pharmaceuticals in India, produces or sells products primarily in three key therapeutic areas.

Their product portfolio includes:

Antibiotics: This category comprises active pharmaceutical ingredients (APIs) and intermediates for sustainable production of various antibiotics. Examples include Amoxicillin, Ampicillin, Cephalexin, Cefadroxil, 6-Aminopenicillanic acid (6-APA), and 7-Aminodeacetoxycephalosporanic acid (7-ADCA).

Statins: They offer APIs for cholesterol-lowering medications. Key products in this area include Pravastatin, Atorvastatin, and Simvastatin.

Antifungals: Their offerings in this segment include APIs for antifungal treatments, such as Nystatin.